Project Number 2020ME_SS Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2020 View Full Project Details for VGF-Derived Peptide Therapy for Alzheimer's Disease: Studies of mouse and human TLQP-21 and its receptor, C3aR1 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 12. Neuroendocrine Mechanisms Researcher and Organization Principal Investigator Ehrlich, Michele, and Salton, Stephen Principal Investigator Ehrlich, Michele, and Salton, Stephen Awardee Organization Mount Sinai Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement 2020 Research Grants FY Overall Cost $172,500 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States Program Official CureAlzFund
